Form 4 for ELTX Elicio Therapeutics, Inc.
Accepted 2021-12-15 00:00:00 ET · period of report 2021-12-14 · accession 0001601485-21-000083 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-12-15 | 2021-12-14 | ELTX | Rhodes Jennifer J | See Remarks | S - Sale | $2.42 | -451 | 30.4K | -1% | -$1,091 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-12-14 | S | D | 451 | $2.42 | 30,399 | D | — | — | (F2) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.41 to $2.42 inclusive. |